I recently had the privilege of being named a Fellow for No Patient Left Behind. I am grateful and excited to be a part of and work with such an esteemed organization to bring Affordability and Innovation to the medical industry. Over the summer, I will be working with other students and leaders across the biotech industry to deliver affordable healthcare and reduce out-of-pocket costs that patients pay for medical treatments, insurance, and devices. If you would also like to be involved with the organization, consider joining as a First Responder or Thought Partner on the No Patient Left Behind website!
Aaveg Mishra’s Post
More Relevant Posts
-
🌟 Exciting Panel Announcement! 🌟 Meet Russell, our panel member for MIC's Biggest Conversation! 🎙️ Currently leading at the Medicines and Healthcare products Regulatory Agency (MHRA), Russell spearheads the regulation of Artificial Intelligence as a Medical Device (AIaMD). Get ready for an insightful discussion as Russell shares his wealth of knowledge at MIC's Biggest Conversation! 🗣️ #MICsBiggestConversation #AIinMedicine #PanelSpeaker #AIEvent #Maidstone 🚀
To view or add a comment, sign in
-
-
Enjoying day 1 of OCT UK and Ireland. I’m here representing Fisher Clinical Services, talking to sponsors about their plans for clinical trials and how we can support with industry leading clinical packaging and supply services. If you’re here be sure to say hello. #OCT #ClinicalTrials #ClinicalStudies #ClinicalSupply #DrugDevelopment
To view or add a comment, sign in
-
-
FDA can be your Partner. In my career, I’ve seen many different approaches of companies to FDA: including confusion, arrogant disregard, and trepidation. However, the key to successful interaction is early engagement and forming a sense of partnership. Why? Because regulators want to bring new therapies to the patient as much as we do, with an eye first on safety, then on efficacy. A perfect example of partnership is a group with which I am quite honored to be affiliated: the CCALC (Cross-Company-Abuse-Liability-Council), which was founded in 2006. One purpose of CCALC is to define best-practice in determining whether a new drug is likely to become a drug of abuse. We continue regularly to meet with FDA, DEA and NIH in order to ensure that we, as an industry, remain at the top of our game. 😊
To view or add a comment, sign in
-
Speed, Efficiency, and quality. Good people, and processes aligned with client vision = Success
RQM+ is proud to be a leading MedTech CRO, with a legacy spanning 40 years in the industry. Our Chief Operating Officer of Clinical Trial Services, David Novotny, shares insights into what sets us apart: a focus on 𝘀𝗽𝗲𝗲𝗱, 𝗲𝗳𝗳𝗶𝗰𝗶𝗲𝗻𝗰𝘆, 𝗾𝘂𝗮𝗹𝗶𝘁𝘆, and 𝗰𝗼𝗺𝗺𝘂𝗻𝗶𝗰𝗮𝘁𝗶𝗼𝗻. He's joined by Chief Customer Officer, Eric Pauls. As a MedTech-only CRO, we offer a full range of services across medical devices, IVDs, software, and combination products. Our team's expertise allows us to be 𝗮 𝗼𝗻𝗲-𝘀𝘁𝗼𝗽 𝘀𝗼𝗹𝘂𝘁𝗶𝗼𝗻 𝗳𝗼𝗿 𝗰𝗹𝗶𝗲𝗻𝘁𝘀 𝗼𝗳 𝗮𝗹𝗹 𝘀𝗶𝘇𝗲𝘀, ensuring knowledge continuity throughout the project lifecycle. 🤝 Watch the video to learn more about our distinct advantages and vision for growth in the coming years. 📈 After one more video with David and Eric this week, we'll be launching into a new educational video series designed to share our knowledge and best practices in clinical trial strategy, execution, and regulatory expertise. We're just getting started and hope you'll join us on this exciting journey. #MedTech #CRO #ClinicalTrials #MedicalDevices #IVDs #CombinationProducts
RQM+: A Leading MedTech CRO with 40 Years of Expertise
To view or add a comment, sign in
-
What's the pre-commercial phase look like? It's all about optimizing your plan and team to navigate a successful transition from trials to launch 👉https://rsm.us/40Tu7fq
Pre-commercial Biopharma: Your therapeutic is ready for the big stage; are you?
rsmus.com
To view or add a comment, sign in
-
Psephos’ Irfan Hassan is attending the UK Regulatory Science & Innovation Networks Programme: Collaborative Networking Event today in London. Innovate UK and Innovate UK Business Connect welcome Discovery Phase Regulatory Science & Innovation Networks to come together with stakeholders from all parts of Innovate UK, the Office for Life Sciences, Medicines and Healthcare products Regulatory Agency (MHRA), and the wider regulatory and policy landscape to share best practice and explore options for future collaboration. We wish you all a successful day and are looking forward to hearing about the potential collaborations. #medtech #medicaldevices #lifesciences #MHRA #regulatorycompliance
To view or add a comment, sign in
-
We recently hosted the MassMedic Regulatory Roundup, a must-attend event for RA, QA, and C-level executives in the medical device industry. Attendees gained valuable insights on the latest global and domestic regulatory issues affecting the industry. We're proud to support the medical device community and help drive innovation in healthcare. #KPMG #MassMedic #RegulatoryRoundup #MedicalDeviceIndustry #HealthcareInnovation #KPMGBoston
KPMG Boston Hosts MassMedic Regulatory Roundup
To view or add a comment, sign in
-
In an era of renewed fiscal responsibility are you doing everything you can to reduce clinical trial costs while maximizing resources?
Reducing Costs, Maximizing Resources: The ISS Nexus Advantage
innovativesupplysolutions.com
To view or add a comment, sign in
-
Are you attending #RAPSConvergence? Stop by booth #300 to meet the Certara team. On October 5, be sure to attend Heather Graham and Trevor Standish’s presentation on "The Evolution of Regulatory Submissions and Technology." Explore how regulatory processes and tech are changing for faster access to medicine. Learn more: https://ow.ly/eomg50PPix4
RAPS Convergence 2023
certara.com
To view or add a comment, sign in
-
CROs Maximize Efficiency, Minimize Effort: Explore CTB's revolutionary approach to proposal creation. Spend less time on paperwork, more on winning clinical trials. #EfficiencyUnlocked #CTB #clinicaltrials #clinicalresearch #clinicaltrial #clinicalresearchjobs
To view or add a comment, sign in